In this issue:
Recommendation against PSA screening and prostate cancer-specific mortality
Abiraterone + ADT and docetaxel for mCSPC
High-dose radiotherapy + ADT in localised prostate cancer
Autologous dendritic cell-based immunotherapy for mCRPC
Tumour genomic testing in mCRPC
Micro-ultrasonography and MRItargeted biopsy
Management of isolated high-grade prostatic intraepithelial neoplasia
PSMA/PET staging of biochemically recurrent cancer for salvage radiation therapy
Expanding active surveillance inclusion criteria
Prostate-only vs whole pelvic radiation therapy
Please login below to download this issue (PDF)